Every recruitment plan starts with a number: how many patients we can identify. Almost none of them budget for the number that actually matters: how many of those patients will enroll. That gap between “identified” and “enrolled” is where trial timelines quietly break. And in patient recruitment, it’s the gap that separates vendors who hand …
In clinical research, there are dozens of metrics that teams track – enrollment rates, screen failures, retention, cost per patient. But one KPI quietly sets the tone for everything that follows: Time-to-First-Patient (TTFP). It sounds simple: how long it takes from site activation to enrolling the first patient – what many sponsors and CROs call …
For decades, patient recruitment has been treated as a downstream task—something to “turn on” after sites are activated, contracts are signed, and timelines are already locked. Too often, it lives in a spreadsheet as a line item rather than in the risk register where it belongs. At ImageBloom, Inc., we see the consequences of this …
At ImageBloom, we’ve seen firsthand how technology is reshaping the clinical trial landscape. Artificial Intelligence (AI) holds enormous promise in patient recruitment, and we leverage it every day to improve efficiency, precision, and scale. But while AI can accelerate parts of the recruitment journey, it can’t replace the human expertise, empathy, and creativity that drive …
If you’ve turned on the TV, scrolled through social media, or flipped through a magazine lately, chances are you’ve seen an ad for a prescription drug. Hello Serena Williams and the latest GLP—1 controversy. This type of promotion—known as direct-to-consumer (DTC) pharmaceutical advertising—is designed to raise awareness, shape perceptions, and encourage patients to ask their …
Conference season is a cornerstone of the clinical research industry, bringing together researchers, site staff, sponsors, CROs, and solution providers in one place. They provide a rare opportunity to exchange knowledge, discover new technologies, and build partnerships that advance clinical trials. At ImageBloom, Inc., we know that conference season is more than just a calendar …
When it comes to clinical trial recruitment, success often hinges on the strength of your partnerships—especially with your recruitment vendors. Yet, many sponsors and CROs overlook critical questions that could make or break their enrollment timelines and overall trial success. If you’re vetting a recruitment partner—or already working with one—here are some key questions you …
By Brandy Church, CEO of ImageBloom, Inc. Patient recruitment has always been a high-stakes, high-cost challenge. Sponsors often pour significant resources into recruitment efforts, only to face delays, low enrollment rates, and underwhelming returns. After over a decade in the industry including years at the site level, I’ve seen firsthand how avoidable inefficiencies drain both …
Recruiting patients for clinical trials has long been a complex and resource-intensive process. As digital marketing continues to evolve, Facebook has emerged as a powerful platform for reaching potential study participants on a large scale. With over 3 billion monthly active users worldwide, Facebook offers unmatched targeting capabilities—but it’s not without its limitations. From strict …
Every April, we observe Minority Health Month—a time to raise awareness about the health disparities that disproportionately affect racial and ethnic minority populations. One of the most pressing issues contributing to these disparities is the underrepresentation of minorities in clinical trials. Diverse participation in research is not just a matter of equity—it’s a matter of …